MJA
MJA

Hydroxychloroquine retinopathy: screening needed to prevent blindness

Med J Aust 2010; 192 (11): 668-669.

To the Editor: Hydroxychloroquine is used infrequently (in less than 0.1% of Australians) for the long-term management of chronic conditions (eg, rheumatoid arthritis).1 Hydroxychloroquine retinopathy is a rare but sight-threatening side effect that is usually not reversible.2-5 Various eye screening recommendations for hydroxychloroquine toxicity have been proposed overseas,3-5 but there is no recommended consensus for eye screening in Australia. As a result, screening is currently not uniform or universal, and this sometimes leads to significant consequences.

  • Elvis Ojaimi1,2
  • Robyn H Guymer1,2
  • Tien Y Wong1,2
  • C Alex Harper1,2

  • 1 Medical Retinal Clinic, Royal Victorian Eye and Ear Hospital, Melbourne, VIC.
  • 2 Centre for Eye Research Australia, University of Melbourne, Melbourne, VIC.


Acknowledgements: 

We thank the Medical Photographic Imaging Centre at the Royal Victorian Eye and Ear Hospital for the images.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article